Eli Lilly Corp. buy BMO Capital Markets
Start price
03.07.24
/
50%
€842.00
Target price
03.07.25
€928.23
Performance (%)
-11.94%
Price
26.07.24
€741.50
Summary
This prediction is currently active. The price of Eli Lilly Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.94%. This prediction currently runs until 03.07.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Eli Lilly Corp. | -5.996% |
| iShares Core DAX® | 1.280% |
| iShares Nasdaq 100 | -2.457% |
| iShares Nikkei 225® | -2.006% |
| iShares S&P 500 | -0.662% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $1,001.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€666.00
07.02.24
07.02.24
€802.46
07.02.25
07.02.25
11.70%
26.07.24
26.07.24
